Skeletal Muscle Function in Interstitial Lung Disease
- Sponsor
- University of British Columbia
- Study ID
- NCT03800017
- Status
- Recruiting
Conditions
- Hypersensitivity Pneumonitis
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Nonspecific Interstitial Pneumonia
- Scleroderma
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Hyperoxia — BIOLOGICALParticipants breathe 60% oxygen during exercise
Study Details
Dyspnea (i.e. breathlessness) and exercise intolerance are common symptoms for patients with interstitial lung disease (ILD), yet it is not known why. It has been suggested that muscle dysfunction may contribute to dyspnea and exercise intolerance in ILD. Our study aims to: i) examine differences in the structure and function of the leg muscles in ILD patients, ii) determine if leg muscle fatigue contributes to dyspnea and exercise limitation in patients with ILD, and iii) determine the effects of breathing extra oxygen on leg muscle fatigue, as well as ability to exercise in ILD patients.
Key Dates
- First listed
- Jan 10, 2019
- Start date
- Aug 7, 2024
- Status verified
- May 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: HyperoxiaDuring exercise on visit 4, participants in both groups (i.e., ILD patients and controls) will breathe supplemental oxygen (i.e., 60% oxygen) during constant-load exercise.
- Placebo Comparator: Healthy ControlsDuring exercise on visit 3, participants in both groups (i.e., ILD patients and controls) will breathe ambient air (i.e., 20.93% oxygen) during constant-load exercise.
Primary Outcome Measure
Change in standardized dyspnea score during the constant load exercise test (visit 3) [ Time Frame: Dyspnea will be measured once every minute during exercise on visit 3 (up to 7 weeks after baseline) until participants reach volitional exhaustion (assessed for up to 30 minutes) ]
Central Contacts
- Olivia Ferguson, MSc1-604-806-8835
- Satvir S Dhillon, MSc1-604-806-8835
Related Studies
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)Recruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)Recruiting · University of Chicago · Chicago, Illinois
- Hyperpolarized 129Xe MRI for Imaging Pulmonary FunctionPHASE2 · Recruiting · Bastiaan Driehuys · Durham, North Carolina
- Scleroderma Registry & Repository at the Hospital for Special SurgeryRecruiting · Hospital for Special Surgery, New York · New York, New York